UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Blood, 2012-03, Vol.119 (9), p.1981-1987

2012

Volltextzugriff (PDF)

Music as a Mnemonic Device for Foreign Vocabulary Learning

English Teaching and Learning, 2020-12, Vol.44 (4), p.377-395

Chen, I-Shan Jenny

2020

Volltextzugriff (PDF)

Unlocking the Magic of Gamification for Preschool Language Learners: A Non-digital Approach to Boosting Reading Engagement at Home: 探究非數位遊戲對於提升幼兒居家閱讀之成效

English teaching & learning, 2024, Vol.48 (2), p.155-188

2024

Volltextzugriff (PDF)

Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate

Clinical cancer research, 2005-05, Vol.11 (9), p.3425-3432

2005

Volltextzugriff (PDF)

Impact of Treatment End Point Definitions on Perceived Differences in Long-Term Outcome With Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3173-3178

2011

Volltextzugriff (PDF)

Multi-Faceted Rasch Measurement and Bias Patterns in EFL Writing Performance Assessment

Psychological reports, 2013-04, Vol.112 (2), p.469-485

2013

Volltextzugriff (PDF)

Clinical Predictors of Response to Rilzabrutinib Therapy in Patients with Immune Thrombocytopenia: Exploratory Analysis of a Phase 1/2 Study

Blood, 2022-11, Vol.140 (Supplement 1), p.5559-5561

2022

Volltextzugriff (PDF)

Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis

Advances in therapy, 2020-01, Vol.37 (1), p.27-40

2020

Volltextzugriff (PDF)

The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors

Blood, 2011-10, Vol.118 (17), p.4541-4546

2011

Volltextzugriff (PDF)

α-MSH and Desacetyl-α-MSH Signaling through Melanocortin Receptors

Annals of the New York Academy of Sciences, 2003-06, Vol.994 (1), p.58-65

2003

Volltextzugriff (PDF)

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

Cancer, 2010-08, Vol.116 (16), p.3830-3834

2010

Volltextzugriff (PDF)

Unlocking the Magic of Gamification for Preschool Language Learners: A Non-digital Approach to Boosting Reading Engagement at Home

English Teaching and Learning, 2024-06, Vol.48 (2), p.155-188

2024

Volltextzugriff (PDF)

Chemical Composition and Toxicity of Particles Emitted from a Consumer-Level 3D Printer Using Various Materials

Environmental science & technology, 2019-10, Vol.53 (20), p.12054-12061

2019

Volltextzugriff (PDF)

Peripherally administered desacetyl {alpha}-MSH and {alpha}-MSH both influence postnatal rat growth and associated rat hypothalamic protein expression

American journal of physiology: endocrinology and metabolism, 2006-12, Vol.291 (6), p.E1372

2006

Volltextzugriff (PDF)

Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy

Blood, 2009-03, Vol.113 (10), p.2154-2160

2009

Volltextzugriff (PDF)

Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure

Blood, 2011-02, Vol.117 (6), p.1822-1827

2011

Volltextzugriff (PDF)

Peripherally administered desacetyl alpha-MSH and alpha-MSH both influence postnatal rat growth and associated rat hypothalamic protein expression

American journal of physiology: endocrinology and metabolism, 2006-12, Vol.291 (6), p.E1372-E1380

2006

Volltextzugriff (PDF)

Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia

Blood, 2008-08, Vol.112 (3), p.516-518

2008

Volltextzugriff (PDF)

Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia

Cancer, 2011-02, Vol.117 (3), p.572-580

2011

Volltextzugriff (PDF)

Immune Modulation of Minimal Residual Disease in Early Chronic Phase Chronic Myelogenous Leukemia: A Randomized Trial of Frontline High-Dose Imatinib Mesylate With or Without Pegylated Interferon Alpha-2b and Granulocyte-Macrophage Colony-Stimulating Factor

Cancer, 2011-02, Vol.117 (3), p.572-580

2011

Volltextzugriff (PDF)

Staging of chronic myeloid leukemia in the imatinib era : An evaluation of the world health organization proposal

Cancer, 2006-03, Vol.106 (6), p.1306-1315

2006

Volltextzugriff (PDF)

Orexin A receptor 1(OX1R) activation increases expression of cytokines in PC12 cells

The FASEB journal, 2019-04, Vol.33 (S1), p.692.10-692.10

2019

Volltextzugriff (PDF)

Dynamic Prognostic Model to Identify Patients with Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (Mf) At the Highest Risk of Death and Transformation to Acute Myeloid Leukemia

Blood, 2011-11, Vol.118 (21), p.2821-2821

2011

Volltextzugriff (PDF)

L‐lactate Increases Apoptosis in Dopaminergic‐Like PC12 Cells

The FASEB journal, 2018-04, Vol.32 (S1), p.lb468-lb468

2018

Volltextzugriff (PDF)

PVN Orexin Receptor 1 Knockdown Effect on Metabolism and Fluid Homeostasis

The FASEB journal, 2018-04, Vol.32 (S1), p.lb465-lb465

2018

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(226)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(254)

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(119)
Humans
(103)
Female
(77)
Middle Aged
(50)
Oncology
(34)
Risk Factors
(34)
Biological And Medical Sciences
(33)
Aged
(31)
Adult
(30)
Medical Sciences
(29)
Case-Control Studies
(28)
Male
(28)
Breast Cancer
(27)
Ovarian Cancer
(26)
Genetic Predisposition To Disease
(23)
Tumors
(23)
Animals
(21)
Breast Neoplasms - Genetics
(20)
Science & Technology - Other Topics
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Music as a Mnemonic Device for Foreign Vocabulary Learning

Unlocking the Magic of Gamification for Preschool Language Learners: A Non-digital Approach to Boosting Reading Engagement at Home: 探究非數位遊戲對於提升幼兒居家閱讀之成效

Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate

Impact of Treatment End Point Definitions on Perceived Differences in Long-Term Outcome With Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

Multi-Faceted Rasch Measurement and Bias Patterns in EFL Writing Performance Assessment

Clinical Predictors of Response to Rilzabrutinib Therapy in Patients with Immune Thrombocytopenia: Exploratory Analysis of a Phase 1/2 Study

Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis

The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors

α-MSH and Desacetyl-α-MSH Signaling through Melanocortin Receptors

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

Unlocking the Magic of Gamification for Preschool Language Learners: A Non-digital Approach to Boosting Reading Engagement at Home

Chemical Composition and Toxicity of Particles Emitted from a Consumer-Level 3D Printer Using Various Materials

Peripherally administered desacetyl {alpha}-MSH and {alpha}-MSH both influence postnatal rat growth and associated rat hypothalamic protein expression

Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy

Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure

Peripherally administered desacetyl alpha-MSH and alpha-MSH both influence postnatal rat growth and associated rat hypothalamic protein expression

Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia

Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia

Immune Modulation of Minimal Residual Disease in Early Chronic Phase Chronic Myelogenous Leukemia: A Randomized Trial of Frontline High-Dose Imatinib Mesylate With or Without Pegylated Interferon Alpha-2b and Granulocyte-Macrophage Colony-Stimulating Factor

Staging of chronic myeloid leukemia in the imatinib era : An evaluation of the world health organization proposal

Orexin A receptor 1(OX1R) activation increases expression of cytokines in PC12 cells

Dynamic Prognostic Model to Identify Patients with Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (Mf) At the Highest Risk of Death and Transformation to Acute Myeloid Leukemia

L‐lactate Increases Apoptosis in Dopaminergic‐Like PC12 Cells

PVN Orexin Receptor 1 Knockdown Effect on Metabolism and Fluid Homeostasis

Suchergebnisse filtern